HEADER CYTOKINE 24-MAY-21 7MZX TITLE AUGALPHA - FAM150B - ALKL2 77-152 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALK AND LTK LIGAND 2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 77-152; COMPND 5 SYNONYM: AUGMENTOR ALPHA,AUG-ALPHA,PROTEIN FAM150B; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ALKAL2, FAM150B, UNQ542/PRO1097; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS ANAPLASTIC LYMPHOMA KINASE ACTIVATING LIGAND, FAM150B, ALKL2 77-152, KEYWDS 2 CYTOKINE EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR P.ROSSI,M.SOWAILEH,A.V.RESHETNYAK,C.G.KALODIMOS REVDAT 5 23-OCT-24 7MZX 1 REMARK REVDAT 4 14-JUN-23 7MZX 1 REMARK REVDAT 3 15-DEC-21 7MZX 1 JRNL REVDAT 2 08-DEC-21 7MZX 1 JRNL REVDAT 1 24-NOV-21 7MZX 0 JRNL AUTH A.V.RESHETNYAK,P.ROSSI,A.G.MYASNIKOV,M.SOWAILEH,J.MOHANTY, JRNL AUTH 2 A.NOURSE,D.J.MILLER,I.LAX,J.SCHLESSINGER,C.G.KALODIMOS JRNL TITL MECHANISM FOR THE ACTIVATION OF THE ANAPLASTIC LYMPHOMA JRNL TITL 2 KINASE RECEPTOR. JRNL REF NATURE V. 600 153 2021 JRNL REFN ESSN 1476-4687 JRNL PMID 34819673 JRNL DOI 10.1038/S41586-021-04140-8 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS, PSVS, PDBSTAT REMARK 3 AUTHORS : BRUNGER, ADAMS, CLORE, GROS, NILGES AND READ REMARK 3 (CNS), BHATTACHARYA AND MONTELIONE (PSVS), TEJERO REMARK 3 AND MONTELIONE (PDBSTAT) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: RESTRAINED MD IN EXPLICIT H2O BATH REMARK 4 REMARK 4 7MZX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 25-MAY-21. REMARK 100 THE DEPOSITION ID IS D_1000256711. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 7.0 REMARK 210 IONIC STRENGTH : 170 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 300 UM [U-100% 13C; U-100% 15N] REMARK 210 AUGALPHA-FAM150B- RESIDUES 77- REMARK 210 152, 150 MM SODIUM CHLORIDE, 20 REMARK 210 MM SODIUM PHOSPHATE, 0.1 % REMARK 210 SODIUM AZIDE, 90% H2O/10% D2O; REMARK 210 300 UM U-15N, U-1H,13C_CH3_ REMARK 210 AILMTV AUGALPHA-FAM150B- REMARK 210 RESIDUES 77-152, 150 MM SODIUM REMARK 210 CHLORIDE, 20 MM SODIUM PHOSPHATE, REMARK 210 0.1 % SODIUM AZIDE, 90% H2O/10% REMARK 210 D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 1H-13C HSQC REMARK 210 ALIPHATIC; 2D 1H-13C HSQC REMARK 210 AROMATIC; 3D 1H-13C NOESY; 3D 1H- REMARK 210 15N NOESY; 3D HNCA; 3D HNCACB; REMARK 210 3D HNCO; 3D CBCA(CO)NH; 3D REMARK 210 HBHA(CO)NH; 3D HCCH-COSY; 3D REMARK 210 HCCH-TOCSY; 3D HNCACO; 3D CCH_ REMARK 210 TOCSY; 3D SOFAST_CCH_NOESY; 3D REMARK 210 SOFAST_HALLCMHM_NOESY; 3D SOFAST_ REMARK 210 HALLNH_NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 700 MHZ; 850 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE NEO REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CYANA 3.98, PINE, NMRFAM-SPARKY, REMARK 210 TOPSPIN 4.06, NMRPIPE, TALOS-N REMARK 210 METHOD USED : MOLECULAR DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ARG A 83 -57.02 -163.00 REMARK 500 1 PRO A 88 174.69 -57.68 REMARK 500 1 ASP A 90 1.73 -68.02 REMARK 500 1 LEU A 91 -8.67 -56.37 REMARK 500 1 TYR A 106 -5.80 -53.61 REMARK 500 1 PHE A 107 -166.20 53.93 REMARK 500 1 TYR A 130 36.44 -96.56 REMARK 500 2 GLU A 81 -76.66 -57.42 REMARK 500 2 ARG A 89 -19.08 -46.83 REMARK 500 2 ASP A 90 -8.59 -59.46 REMARK 500 2 PHE A 107 -158.74 52.43 REMARK 500 2 TYR A 130 39.81 -91.86 REMARK 500 3 GLU A 81 -73.28 -60.18 REMARK 500 3 ARG A 83 -50.77 -174.99 REMARK 500 3 TYR A 106 -9.96 -52.71 REMARK 500 3 PHE A 107 -164.95 51.04 REMARK 500 3 TYR A 130 32.95 -94.26 REMARK 500 3 PRO A 145 -37.40 -37.72 REMARK 500 4 ASP A 90 1.36 -68.59 REMARK 500 4 PHE A 107 -160.39 50.87 REMARK 500 4 TYR A 130 38.15 -94.43 REMARK 500 5 GLU A 81 -72.69 -64.63 REMARK 500 5 ARG A 83 -62.22 -147.56 REMARK 500 5 PRO A 88 176.25 -50.49 REMARK 500 5 ASP A 90 4.72 -66.14 REMARK 500 5 PHE A 107 132.97 52.83 REMARK 500 5 TYR A 130 47.68 -99.08 REMARK 500 5 MET A 148 -73.52 -92.39 REMARK 500 6 GLU A 81 -97.33 19.30 REMARK 500 6 ARG A 89 -8.52 -53.95 REMARK 500 6 TYR A 106 -8.14 -55.24 REMARK 500 6 PHE A 107 -156.87 50.88 REMARK 500 6 CYS A 111 -3.42 -143.03 REMARK 500 6 TYR A 130 51.21 -101.75 REMARK 500 6 PRO A 145 -15.48 -47.67 REMARK 500 7 GLU A 81 -58.40 -122.72 REMARK 500 7 GLN A 82 61.24 -105.66 REMARK 500 7 GLU A 85 2.29 -65.68 REMARK 500 7 ASP A 90 3.24 -69.72 REMARK 500 7 TYR A 106 -8.61 -53.21 REMARK 500 7 PHE A 107 -157.34 49.36 REMARK 500 7 TYR A 130 55.53 -94.14 REMARK 500 8 ARG A 83 -63.67 -129.75 REMARK 500 8 ARG A 89 -18.27 -48.79 REMARK 500 8 TYR A 106 15.32 -56.35 REMARK 500 8 PHE A 107 175.86 72.15 REMARK 500 8 TYR A 130 34.01 -98.56 REMARK 500 8 ASP A 150 96.73 -178.93 REMARK 500 9 PRO A 80 92.51 -68.40 REMARK 500 9 ARG A 83 -70.04 -175.75 REMARK 500 REMARK 500 THIS ENTRY HAS 109 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7MZW RELATED DB: PDB REMARK 900 ALK-NMR REMARK 900 RELATED ID: 7N00 RELATED DB: PDB REMARK 900 2ALK-2AUGAPHA-CRYOEM REMARK 900 RELATED ID: 7MZY RELATED DB: PDB REMARK 900 ALK-XAY REMARK 900 RELATED ID: 7MZX RELATED DB: PDB REMARK 900 AUGALPHA-NMR REMARK 900 RELATED ID: 7MZZ RELATED DB: PDB REMARK 900 AUGBETA-NMR REMARK 900 RELATED ID: 30911 RELATED DB: BMRB REMARK 900 AUGALPHA - FAM150B - ALKL2 77-152 DBREF 7MZX A 77 152 UNP Q6UX46 ALKL2_HUMAN 77 152 SEQRES 1 A 76 GLY PRO SER PRO GLU GLN ARG VAL GLU ILE VAL PRO ARG SEQRES 2 A 76 ASP LEU ARG MET LYS ASP LYS PHE LEU LYS HIS LEU THR SEQRES 3 A 76 GLY PRO LEU TYR PHE SER PRO LYS CYS SER LYS HIS PHE SEQRES 4 A 76 HIS ARG LEU TYR HIS ASN THR ARG ASP CYS THR ILE PRO SEQRES 5 A 76 ALA TYR TYR LYS ARG CYS ALA ARG LEU LEU THR ARG LEU SEQRES 6 A 76 ALA VAL SER PRO VAL CYS MET GLU ASP LYS GLN HELIX 1 AA1 PRO A 88 LEU A 91 5 4 HELIX 2 AA2 ARG A 92 GLY A 103 1 12 HELIX 3 AA3 CYS A 111 ASN A 121 1 11 HELIX 4 AA4 THR A 122 ILE A 127 1 6 HELIX 5 AA5 TYR A 130 VAL A 143 1 14 SSBOND 1 CYS A 111 CYS A 147 1555 1555 2.02 SSBOND 2 CYS A 125 CYS A 134 1555 1555 2.02 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1